GABAA Receptor D N-Terminus Antibody

<strong>GABAA Receptor D N-Terminus Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2013978_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 µL_x000D_ <strong>Molecular Weight or Concentration:</strong> 52 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> ‚àí20¬∞C_x000D_ <strong>Keywords:</strong> Rabbit GABAA Receptor D N-Terminus_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Silva MH, Gammon D. An assessment of the developmental, reproductive, and neurotoxicity of endosulfan Birth Defects Res B Dev Reprod Toxicol. 2009 Feb;86(1):1-28._x000D_ 2: Little JZ, Teyler TJ. GABAa receptor-mediated field potentials are enhanced in area CA1 following prenatal cocaine exposure Brain Res Dev Brain Res. 1998 Sep 10;110(1):115-9._x000D_ 3: Bassett ML, Mullen KD, Skolnick P, Jones EA. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure Gastroenterology. 1987 Nov;93(5):1069-77._x000D_ 4: Van der Weide J, De Vries JB, Tepper PG, Krause DN, Dubocovich ML, Horn AS. N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo models Eur J Pharmacol. 1988 Mar 1;147(2):249-58._x000D_ 5: Thiels E, Xie X, Yeckel MF, Barrionuevo G, Berger TW. NMDA receptor-dependent LTD in different subfields of hippocampus in vivo and in vitro Hippocampus. 1996;6(1):43-51._x000D_ 6: Chaffiol A, Ishii M, Cao Y, Mangel SC. Dopamine Regulation of GABA(A) Receptors Contributes to Light/Dark Modulation of the ON-Cone Bipolar Cell Receptive Field Surround in the Retina Curr Biol. 2017 Sep 11;27(17):2600-2609.e4._x000D_ 7: Blanpied TA, Berger TW. Characterization in vivo of the NMDA receptor-mediated component of dentate granule cell population synaptic responses to perforant path input Hippocampus. 1992 Oct;2(4):373-88._x000D_ 8: Iasnetsov VV, Prosvirova EP, Motin VG, Karsanova SK, Chel'naia NA, Iasnetsov VV. [Analgesic effect of succinate-containing preparations] Eksp Klin Farmakol. 2013;76(4):11-4._x000D_ 9: Zbarska S, Bracha V. Assessing the role of inferior olivary sensory signaling in the expression of conditioned eyeblinks using a combined glutamate/GABAA receptor antagonist protocol J Neurophysiol. 2012 Jan;107(1):273-82._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/1326004">10: Vogt LJ, Vogt BA, Sikes RW. Limbic thalamus in rabbit: architecture, projections to cingulate cortex and distribution of muscarinic acetylcholine, GABAA, and opioid receptors J Comp Neurol. 1992 May 8;319(2):205-17. </a>_x000D_ _x000D_ <strong>Products Related to GABAA Receptor D N-Terminus Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>